Effect of different doses of ursodeoxycholic acid in chronic liver disease

Digestive Diseases and Sciences

Volumn 34, Issue 12 Supplement, 1989, Pages

  Podda, M ^a,b   Ghezzi, C ^a,b   Battezzati, P M ^a,b   Bertolini, E ^a,b   Crosignani, A ^a,b   Petroni, M L ^a,b   Zuin, M ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

chronic hepatitis; dose response; liver enzymes; primary biliary cirrhosis; primary sclerosing cholangitis; ursodiol

Indexed keywords

URSODEOXYCHOLIC ACID;

CHOLANGITIS; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONFERENCE PAPER; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

BILE; BILIRUBIN; CHOLANGITIS, SCLEROSING; COMPARATIVE STUDY; DEOXYCHOLIC ACID; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEPATITIS, CHRONIC; HUMAN; LIPIDS; LIVER CIRRHOSIS, BILIARY; LIVER FUNCTION TESTS; MALE; MIDDLE AGE; RANDOM ALLOCATION; TIME FACTORS; URSODEOXYCHOLIC ACID;

EID: 0024834972     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/BF01536665     Document Type: Article

References (30)

1. Effect of chenodeoxycholic and ursodeoxycholic acids on isolated adult human hepatocytes
2. Anti-cholestatic and cytoprotective properties of ursodeoxycholic acid. Studies in vivo and in vitro
3. Comparison of the effects between ursodeoxycholic and chenodeoxycholic acids on liver function and structure and on bile acid composition in the rhesus monkey
4. Early morphologic and enzymatic changes in livers of rats treated with chenodeoxycholic and ursodeoxycholic acids
5. Ursodeoxycholic acid: A review of its pharmacological property and therapeutic efficacy
6. Differing effects of nor-ursodeoxycholic or ursodeoxycholic acid on hepatic histology and bile acid metabolism in the rabbit
7. Tauroursodeoxycholate reduces ductular proliferation and portal inflammation in bile duct-ligated hamsters
8. Chenodeoxycholic acid and the liver: Good news—bad news
9. Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study
10. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?
11. Die Wirkung von Ursodesoxycholsaure bei chronischen Lebererkrankungen: Eine Pilotstudie
12. Influence of ursodeoxycholic acid on biochemical parameters in cholestatic liver disease
13. Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis
14. Long-term administration of ursodeoxycholic acid in patients with chronic hepatitis. A comparison of the effect of two doses on liver function
15. Ursodeoxycholic acid for chronic liver diseases
16. Influence of hydroxylation and conjugation of bile salts on their membrane-damaging properties. Studies on isolated hepatocytes and lipid membrane vesicles
17. Effects of bile acids on the cultured hepatocyte and Kupffer cell
18. Impaired lithocholate sulfation in the rhesus monkey: A mechanism for chenodeoxycholate toxicity
19. Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: The National Cooperative Gallstone Study. A controlled trial of efficacy and safety
20. Effect of deoxycholic acid ingestion on bile acid metabolism and biliary lipid secretion in normal subjects
21. Clinical-pathologic relations in primary biliary cirrhosis
22. The hydrophobic-hydrophilic balance of bile salts. Inverse correlation between reversephase high performance liquid chromatographic mobilities and micellar cholesterol-solubilizing capacities
23. Bile acid-induced liver toxicity: Relation to the hydrophobic-hydrophilic balance of bile acids
24. Serum bilirubin: A prognostic factor in primary biliary cirrhosis
25. Beneficial effects of azathioprine and prediction of prognosis in primary biliary cirrhosis